Alana Cattapan questions the balance between clinic profits and costs to patients in the Canadian infertility business.
Françoise Baylis and Jocelyn Downie comment on the first prosecution under the Assisted Human Reproduction Act and criticize Health Canada for its ongoing failure (since 2004) to draft the regulations on reimbursement of receipted expenses.
Cynthia Martin reports on what cartoonists reflected in visual narratives of stem cell science.
Matthew Herder explains why Health Canada’s “life cycle” approach to drug regulation may be beyond the regulator’s mandate.
Ellen K. Feder questions the effect of the new category on German birth certificates.


